décolletage laxity glp-1 therapy treatment Journal of Aesthetic Nursing - A topical approach to GLP-1/GIP agonist-induced tissue changes in the face, neck and décolletage: a case series evaluation Skin Laxity After Weight Loss

Is 500 mg glutathione enough for skin whitening

Novo Nordisk and the Next Wave of Weight Loss Drugs The Two-Company Market: Q1 2026 Head to Head Key Numbers Total Revenue: $19.8B (+56% YoY) Adjusted EPS: $8.55 (+156%) Mounjaro: $8.66B (+100%+ YoY) Zepbound: $4.16B (+80% YoY) US Market Share: 60.1% 2026 Guide: $82-85B (raised $2B) Total Revenue: $10.8B (beat estimates) Adjusted EPS: $1.03 (beat) Wegovy: DKK 18.2B (+12% YoY) Wegovy Pill: $354M (doubled estimates) US Market Share: 39.4% 2026 Guide: Adjusted sales decline 4-12% at CER The GLP-1 market in 2026 is a two-company duopoly with a widening gap

While many people see positive results, a frequent complaint is persistent bloating or abdominal distension

No amount of sleep feels enough